Versant Capital Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
MBAM
Versant Capital Management's OPRX Position: Q3 2026 in Review
Versant Capital Management held its OptimizeRx (OPRX) position steady in Q3 2026 at 1,061 shares worth $8.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2301.
Versant Capital Management first reported a position in OPRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $36.8K in Q3 2025. 103 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.
- Versant Capital Management held 1,061 shares of OptimizeRx worth $8.86K as of Q3 2026.
- Versant Capital Management left its OptimizeRx share count unchanged in Q3 2026.
- OptimizeRx made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2301 holding.
- Versant Capital Management first reported a position in OptimizeRx in Q4 2024 and has held it in 8 quarters since.
- Versant Capital Management's OptimizeRx position peaked at $36.8K in Q3 2025.
- 103 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.